Home Profile Services HCC Leadership Clients News Events Contact Contact
Valuation Consulting Commercial Reasonableness Commercial Payor Reimbursement-benchmarking Litigationsupport Expertwitness Financial Analysis Modeling Intermediary Services Certificate of Need ACO Valuemetrics Strategic Consulting Industry Research Services







To offset increasing costs and expenditures, healthcare reimbursement has begun shifting from volume to value, most recently manifested in the 2010 Patient Protection and Affordable Care Act (ACA) and the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA). Although value-based reimbursement (VBR) programs are relatively new, recently-published preliminary evaluations of the programs have been disappointing, and, in conjunction with the organizational directives of newly-appointed Centers for Medicare and Medicaid Services (CMS) leadership, have prompted significant changes to existing VBR programs and the creation of a new VBR program.
 To offset increasing costs and expenditures, healthcare reimbursement has begun shifting from volume to value, most recently manifested in the 2010 Patient Protection and Affordable Care Act (ACA) and the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA). Although value-based reimbursement (VBR) programs are relatively new, recently-published preliminary evaluations of the programs have been disappointing, and, in conjunction with the organizational directives of newly-appointed Centers for Medicare and Medicaid Services (CMS) leadership, have prompted significant changes to existing VBR programs and the creation of a new VBR program.  (Read more...) 
As discussed in the first installment of this four-part series, trademarks and trade names are symbols that represent an intangible quality of the good or service provided under the trademark/trade name.  These attributes might include quality, reliability, and/or dependability, and they may be classified generally as reputational. Value for a trademark/trade name arises from its ability to transfer this reputational quality to a product or service. Trademarks and trade names are both components of the brand of a business entity. The first part of this four-part series set forth an overview of trademark and trade name valuation as it relates to the healthcare industry. This second installment will review the economic benefits accruing to the consumers of the trademark or trade name (i.e., patients).  (Read more...) 
On December 21, 2017, the U.S. Department of Justice (DOJ) announced their recovery of more than $3.7 billion in settlements and judgments from civil cases involving fraud and false claims for fiscal year (FY) 2017. This amount is the fourth largest recovery in thirty years, and the eighth consecutive year in which healthcare fraud settlements exceeded $2 billion. Approximately $2.4 billion was recouped from the healthcare industry for federal losses alone, and included recoveries from drug companies, hospitals, pharmacies, laboratories, and physicians. This figure, almost 65 percent of the total recovery amount, is much higher than the $220 million recovered from defense contractor companies and the $1 billion obtained from other industries such as banking, higher education, and energy. In addition to the $2.4 billion recovered for federal losses, the DOJ recovered millions of dollars for state and Medicaid programs for FY 2017.  (Read more...)
 The first installment of this six-part series set forth an overview of the due diligence imperative for valuation professionals, in the context of the Four Pillars of Healthcare Value, i.e.,  Reimbursement, Regulatory, Technology, and Competition. The second through fifth installments reviewed the due diligence process related to the reimbursement, regulatory, competitive and technological environments, respectively. This series conclusion will review the due diligence process generally as it relates to the healthcare industry.  (Read more...)
ANNOUNCING
 
Advanced Distance Education to Launch in 2018

The Institute for Healthcare Valuation (IHV) & Consultants' Training Institute (CTI) are pleased to announce premier healthcare valuation training through a distance education program, the Certificate of Educational Achievement (CEA) for Advanced Education in Healthcare Valuation. The program will launch in 2018 and will bridge the interdisciplinary nature of healthcare valuation to include: the Four Pillars of Healthcare (regulatory, reimbursement, competition, and technology); the market forces shaping the U.S. healthcare industry; and the valuation of healthcare enterprises, assets, and services. Legal professionals and healthcare providers, as well as those wishing to expand their scope of activities in healthcare valuation engagements and those seeking to enhance their current healthcare valuation service lines, will gain comprehensive knowledge through completing the expansive program. The program has been developed and is being presented by industry thought leader Health Capital Consultants, alongside a blockbuster faculty of healthcare subject matter experts from the legal, federal regulatory, and valuation professions.


HCC President, Todd Zigrang, is honored to have co-authored the chapter entitled, "The Threshold of Commercial Reasonableness," in BVR/AHLA's newly published Guide to Valuing Physician Compensation and Healthcare Service Arrangements (2nd Edition).